Celltrion Pharm Inc. (068760.KQ) reported Thursday higher profit and sales in fiscal 2025.
In South Korea, the shares were trading at 70,100 won, up 0.21 percent.
In the year, net income climbed 76.42% to 38.752 billion Korean won from last year's 21.966 billion won.
Operating income grew 50.69 percent to 56.092 billion won from 37.223 billion won a year ago.
Sales increased 12.26 percent to 536.400 billion won from 477.835 billion won last year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.